Fixed-Life or Rechargeable Battery for Deep Brain Stimulation: Which Do Patients Prefer?

Khaleeq, Tahir; Hasegawa, Harutomo; Samuel, Michael; Ashkan, Keyoumars

doi:10.1111/ner.12810

Cited by 30 publications

(21 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Lam and Rosenow reported that patients in whom the recharging burden outweighed benefits of increased battery life were significantly older (74 years) than those who felt that the tradeoff was worthwhile (56 years) [25]. However, in other surveys an age or gender dependency has not been found [22].…”

Section: Treatment Compliance and Disease Awarenessmentioning

confidence: 98%

“…Although there are currently no patient preference studies of SNM in terms of rechargeable versus recharge-free devices, some conclusions can be drawn from patient surveys in spinal cord stimulation (SCS) or deep brain stimulation (DBS) therapies, where rechargeable devices have been used for more than 10 years. In a survey of 30 patients with movement disorders visiting a pre-DBS clinic (mean age 65, range 45-79 years), 63% chose the recharge-free device compared to 37% for the rechargeable device, even though the battery longevity of the recharge-free device was estimated at only 3-5 years [22]. In a multicenter, retrospective study with 352 explanted SCS patients it was reported that patients with rechargeable devices terminated their therapy earlier than patients with recharge-free devices [23].…”

Section: Treatment Compliance and Disease Awarenessmentioning

confidence: 99%

See 1 more Smart Citation

New Technologies and Applications in Sacral Neuromodulation: An Update

et al. 2019

View full text Add to dashboard Cite

Recently rechargeable devices have been introduced for sacral neuromodulation (SNM) with conditional safety for full-body magnetic resonance imaging (MRI). Currently a recharge-free SNM device represents the standard implant; however, it is only approved for MRI head scans. As further new technologies with broader MRI capabilities are emerging, the advantages as well as disadvantages of both rechargeable versus recharge-free devices will be briefly discussed in this commentary from the perspective of patients, healthcare professionals, and providers.

show abstract

Section: Treatment Compliance and Disease Awarenessmentioning

confidence: 98%

Section: Treatment Compliance and Disease Awarenessmentioning

confidence: 99%

New Technologies and Applications in Sacral Neuromodulation: An Update

et al. 2019

View full text Add to dashboard Cite

show abstract

“…Owing to such pros and cons, the attitude toward this approach is inconclusive. Acceptance toward RC implants is high in some studies while 63% indicated fixed-life battery as a more preferable option in another study, due to convenience and concerns of forgetting to recharge the battery [48]- [50].…”

Section: Power Transmission and Harvestingmentioning

confidence: 99%

Challenges in Scaling Down of Free-Floating Implantable Neural Interfaces to Millimeter Scale

Yang

2020

IEEE Access

View full text Add to dashboard Cite

Implantable neural interface devices are an emerging technology for continuous brain monitoring and brain-computer interface (BCI). Recording of electrical signals from neurons of interest has led to more efficient and personalized diagnosis, treatment, and prognosis of neurological disorders. It facilitates the dynamic mapping of the whole brain, improving our understanding of the links between brain functions and behaviors. Stimulation of targeted nerves and neurons has been utilized as an effective therapy for Parkinson's disease, essential tremor, dystonia, etc. It has also been developed as motor neuroprosthetic devices, improving the quality of life of many. Although initial designs were bulky, recent advances in semiconductor and nano-, micro-technology has enabled the miniaturization of such devices to the millimeter scale. Free-floating neural implants of miniature size are highly scalable to be distributed around the targeted region of interest more extensively. They are more clinically viable as they cause less disturbance to the body and induce less tissue immune response. However, these research efforts for scaling down have faced challenges resulted from decreasing the size of such implants, including issues pertaining to wireless powering, data communication, neural signal recording, and neural stimulation. Through extensive literature research and simulations, the limits and trade-offs regarding neural implant miniaturization are investigated and analyzed for each aspect of the challenges. State-of-the-art development and future trends for advanced neural interfaces are also explored. INDEX TERMS Implantable neural interface, neural signal recording and stimulation, wireless power transfer, millimeter size, free-floating neural probes.

show abstract

“…One possible strategy to reduce the frequency of depressive episodes may be using rechargeable batteries, which have the benefit of lasting much longer before depletion, and thus may correspond with fewer rebound episodes. That said, patients often express a preference for fixed-life batteries due to a fear of forgetting to charge batteries and finding regular battery charges to be cumbersome [59].…”

Section: Depression and Suicidalitymentioning

confidence: 99%

Improving long term patient outcomes from deep brain stimulation for treatment-refractory obsessive-compulsive disorder

Guzick

Hunt

Bijanki

et al. 2019

Expert Review of Neurotherapeutics

View full text Add to dashboard Cite

Introduction: Deep brain stimulation (DBS) has emerged as an effective treatment for patients with severe treatment-refractory obsessive-compulsive disorder (OCD). Over the past two decades, several clinical trials with multiple years of follow-up have shown that DBS offers long-term symptom relief for individuals with severe OCD, though a portion of patients do not achieve an adequate response. Areas covered: This review sought to summarize the literature on the efficacy and long-term effectiveness of DBS for OCD, and to identify strategies that have the potential to improve treatment outcomes. Expert opinion: Although this literature is just emerging, a small number of DBS enhancement strategies have shown promising initial results. More posterior targets along the striatal axis and at the bed nucleus of the stria terminalis appear to offer greater symptom relief than more anterior targets. Research is also beginning to demonstrate the feasibility of maximizing treatment outcomes with target selection based on neural activation patterns during symptom provocation and clinical presentation. Finally, integrating DBS with post-surgery exposure and response prevention therapy appears to be another promising approach. Definitive conclusions about these strategies are limited by a low number of studies with small sample sizes that will require multisite replication.

show abstract

Fixed-Life or Rechargeable Battery for Deep Brain Stimulation: Which Do Patients Prefer?

Cited by 30 publications

References 17 publications

New Technologies and Applications in Sacral Neuromodulation: An Update

New Technologies and Applications in Sacral Neuromodulation: An Update

Challenges in Scaling Down of Free-Floating Implantable Neural Interfaces to Millimeter Scale

Improving long term patient outcomes from deep brain stimulation for treatment-refractory obsessive-compulsive disorder

Contact Info

Product

Resources

About